A Phase II Trial of R115777 (NSC #702818) [tipifarnib] in Patients With Advanced Pancreas Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2015
At a glance
- Drugs Tipifarnib (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 13 Jun 2012 Actual patient number is 58 according to ClinicalTrials.gov.
- 13 Jun 2012 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 13 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.